β-ニコチンアミドモノヌクレオチド（NMN）の世界市場2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global β-Nicotinamide Mononucleotide (NMN) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-04676 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：化学、材料

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、β-ニコチンアミドモノヌクレオチド（NMN）の世界市場を広く調査・分析し、今後の市場展望をまとめております。β-ニコチンアミドモノヌクレオチド（NMN）の種類別市場規模（純度<98％、純度≥98％）、用途別市場規模（医療用品、化粧品、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GeneHarbor、EffePharm、Shinkowa Pharmaceutical、Herbalmax、Shandong Sihuan Pharmaceutical、Genex Formulas、Bontac、Maac10 Formulas、Zhejiang Jiahua Pharmchemical ・地域別グローバル市場分析 2015年-2020年 ・β-ニコチンアミドモノヌクレオチド（NMN）の北米市場（アメリカ、カナダ、メキシコ） ・β-ニコチンアミドモノヌクレオチド（NMN）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・β-ニコチンアミドモノヌクレオチド（NMN）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・β-ニコチンアミドモノヌクレオチド（NMN）の南米市場（ブラジル、アルゼンチン） ・β-ニコチンアミドモノヌクレオチド（NMN）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：純度<98％、純度≥98％ ・用途別分析：医療用品、化粧品、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The β-Nicotinamide Mononucleotide (NMN) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global β-Nicotinamide Mononucleotide (NMN) sales will be xx in 2020 from β-Nicotinamide Mononucleotide (NMN) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global β-Nicotinamide Mononucleotide (NMN) market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the β-Nicotinamide Mononucleotide (NMN) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on β-Nicotinamide Mononucleotide (NMN) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
β-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, β-Nicotinamide Mononucleotide (NMN) market has been segmented into
Purity ＜98%
Purity ≥98%

By Application, β-Nicotinamide Mononucleotide (NMN) has been segmented into:
Health Care Products
Cosmetics
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global β-Nicotinamide Mononucleotide (NMN) market presented in the report. This section sheds light on the sales growth of different regional and country-level β-Nicotinamide Mononucleotide (NMN) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global β-Nicotinamide Mononucleotide (NMN) market.

The report offers in-depth assessment of the growth and other aspects of the β-Nicotinamide Mononucleotide (NMN) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and β-Nicotinamide Mononucleotide (NMN) Market Share Analysis
β-Nicotinamide Mononucleotide (NMN) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, β-Nicotinamide Mononucleotide (NMN) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the β-Nicotinamide Mononucleotide (NMN) sales, revenue and market share for each player covered in this report.

The major players covered in β-Nicotinamide Mononucleotide (NMN) are:
GeneHarbor
EffePharm
Shinkowa Pharmaceutical
Herbalmax
Shandong Sihuan Pharmaceutical
Genex Formulas
Bontac
Maac10 Formulas
Zhejiang Jiahua Pharmchemical

Among other players domestic and global, β-Nicotinamide Mononucleotide (NMN) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe β-Nicotinamide Mononucleotide (NMN) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of β-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of β-Nicotinamide Mononucleotide (NMN) in 2018 and 2019.
Chapter 3, the β-Nicotinamide Mononucleotide (NMN) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the β-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, β-Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe β-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 β-Nicotinamide Mononucleotide (NMN) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Purity ＜98%
1.2.3 Purity ≥98%
1.3 Market Analysis by Application
1.3.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Overview of Global β-Nicotinamide Mononucleotide (NMN) Market
1.4.1 Global β-Nicotinamide Mononucleotide (NMN) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: β-Nicotinamide Mononucleotide (NMN) Industry Impact
1.6.1 COVID-19 Potential Implications for the β-Nicotinamide Mononucleotide (NMN)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on β-Nicotinamide Mononucleotide (NMN)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GeneHarbor SWOT Analysis
2.1.4 GeneHarbor Product and Services
2.1.5 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 EffePharm
2.2.1 EffePharm Details
2.2.2 EffePharm Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 EffePharm SWOT Analysis
2.2.4 EffePharm Product and Services
2.2.5 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Shinkowa Pharmaceutical
2.3.1 Shinkowa Pharmaceutical Details
2.3.2 Shinkowa Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Shinkowa Pharmaceutical SWOT Analysis
2.3.4 Shinkowa Pharmaceutical Product and Services
2.3.5 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Herbalmax
2.4.1 Herbalmax Details
2.4.2 Herbalmax Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Herbalmax SWOT Analysis
2.4.4 Herbalmax Product and Services
2.4.5 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shandong Sihuan Pharmaceutical
2.5.1 Shandong Sihuan Pharmaceutical Details
2.5.2 Shandong Sihuan Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shandong Sihuan Pharmaceutical SWOT Analysis
2.5.4 Shandong Sihuan Pharmaceutical Product and Services
2.5.5 Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Genex Formulas
2.6.1 Genex Formulas Details
2.6.2 Genex Formulas Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Genex Formulas SWOT Analysis
2.6.4 Genex Formulas Product and Services
2.6.5 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bontac SWOT Analysis
2.7.4 Bontac Product and Services
2.7.5 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Maac10 Formulas
2.8.1 Maac10 Formulas Details
2.8.2 Maac10 Formulas Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Maac10 Formulas SWOT Analysis
2.8.4 Maac10 Formulas Product and Services
2.8.5 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Zhejiang Jiahua Pharmchemical
2.9.1 Zhejiang Jiahua Pharmchemical Details
2.9.2 Zhejiang Jiahua Pharmchemical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Zhejiang Jiahua Pharmchemical SWOT Analysis
2.9.4 Zhejiang Jiahua Pharmchemical Product and Services
2.9.5 Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2019
3.3.2 Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Regions
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Regions (2015-2020)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Regions (2015-2020)
4.2 North America β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
4.3 Europe β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
4.5 South America β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Country
5.1.1 North America β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Country (2015-2020)
5.1.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Country (2015-2020)
5.2 United States β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
5.3 Canada β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
5.4 Mexico β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Country
6.1.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Country (2015-2020)
6.1.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Country (2015-2020)
6.2 Germany β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.3 UK β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.4 France β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.5 Russia β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
6.6 Italy β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Regions (2015-2020)
7.2 China β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7.3 Japan β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7.4 Korea β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7.5 India β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
7.7 Australia β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Country
8.1.1 South America β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Country (2015-2020)
8.1.2 South America β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Country (2015-2020)
8.2 Brazil β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
8.3 Argentina β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.3 Turkey β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.4 Egypt β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
9.5 South Africa β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global β-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Type (2015-2020)
10.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2015-2020)
10.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2015-2020)
11 Global β-Nicotinamide Mononucleotide (NMN) Market Segment by Application
11.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2015-2020)
11.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2015-2020)
11.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2015-2020)
12 Market Forecast
12.1 Global β-Nicotinamide Mononucleotide (NMN) Sales, Revenue and Growth Rate (2021-2025)
12.2 β-Nicotinamide Mononucleotide (NMN) Market Forecast by Regions (2021-2025)
12.2.1 North America β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025)
12.2.2 Europe β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025)
12.2.3 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025)
12.2.4 South America β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025)
12.2.5 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025)
12.3 β-Nicotinamide Mononucleotide (NMN) Market Forecast by Type (2021-2025)
12.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2021-2025)
12.3.2 Global β-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Type (2021-2025)
12.4 β-Nicotinamide Mononucleotide (NMN) Market Forecast by Application (2021-2025)
12.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2021-2025)
12.4.2 Global β-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global β-Nicotinamide Mononucleotide (NMN) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of β-Nicotinamide Mononucleotide (NMN) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global β-Nicotinamide Mononucleotide (NMN) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global β-Nicotinamide Mononucleotide (NMN) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 9. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Major Business
Table 10. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 11. GeneHarbor SWOT Analysis
Table 12. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 13. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. EffePharm Basic Information, Manufacturing Base and Competitors
Table 15. EffePharm β-Nicotinamide Mononucleotide (NMN) Major Business
Table 16. EffePharm β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 17. EffePharm SWOT Analysis
Table 18. EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 19. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 21. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Major Business
Table 22. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 23. Shinkowa Pharmaceutical SWOT Analysis
Table 24. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 25. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 27. Herbalmax β-Nicotinamide Mononucleotide (NMN) Major Business
Table 28. Herbalmax β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 29. Herbalmax SWOT Analysis
Table 30. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 31. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Shandong Sihuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 33. Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Major Business
Table 34. Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 35. Shandong Sihuan Pharmaceutical SWOT Analysis
Table 36. Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 37. Shandong Sihuan Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 39. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Major Business
Table 40. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 41. Genex Formulas SWOT Analysis
Table 42. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 43. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Bontac Basic Information, Manufacturing Base and Competitors
Table 45. Bontac β-Nicotinamide Mononucleotide (NMN) Major Business
Table 46. Bontac β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 47. Bontac SWOT Analysis
Table 48. Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 49. Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 51. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Major Business
Table 52. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 53. Maac10 Formulas SWOT Analysis
Table 54. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 55. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Zhejiang Jiahua Pharmchemical Basic Information, Manufacturing Base and Competitors
Table 57. Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Major Business
Table 58. Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Total Revenue (USD Million) (2018-2019)
Table 59. Zhejiang Jiahua Pharmchemical SWOT Analysis
Table 60. Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 61. Zhejiang Jiahua Pharmchemical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturer (2018-2019) (Kg)
Table 63. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global β-Nicotinamide Mononucleotide (NMN) Sales by Regions (2015-2020) (Kg)
Table 65. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Regions (2015-2020)
Table 66. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Regions (2015-2020) (USD Million)
Table 67. North America β-Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020) (Kg)
Table 68. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries (2015-2020)
Table 69. North America β-Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020) (USD Million)
Table 70. North America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries (2015-2020)
Table 71. Europe β-Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020) (Kg)
Table 72. Europe β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries (2015-2020)
Table 73. Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Regions (2015-2020) (Kg)
Table 75. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Regions (2015-2020) (USD Million)
Table 77. South America β-Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020) (Kg)
Table 78. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries (2015-2020)
Table 79. South America β-Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020) (USD Million)
Table 80. South America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Countries (2015-2020) (Kg)
Table 82. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries (2015-2020)
Table 85. Global β-Nicotinamide Mononucleotide (NMN) Sales by Type (2015-2020) (Kg)
Table 86. Global β-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2015-2020)
Table 87. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2015-2020) (USD Million)
Table 88. Global β-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2015-2020)
Table 89. Global β-Nicotinamide Mononucleotide (NMN) Sales by Application (2015-2020) (Kg)
Table 90. Global β-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2015-2020)
Table 91. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Regions (2021-2025) (Kg)
Table 92. Global β-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Regions (2021-2025)
Table 93. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2021-2025) (Kg)
Table 94. Global β-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Type (2021-2025)
Table 95. Global β-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2021-2025)
Table 96. Global β-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. β-Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global Sales Market Share of β-Nicotinamide Mononucleotide (NMN) by Type in 2019
Figure 3. Purity ＜98% Picture
Figure 4. Purity ≥98% Picture
Figure 5. β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2018
Figure 6. Health Care Products Picture
Figure 7. Cosmetics Picture
Figure 8. Others Picture
Figure 9. Global β-Nicotinamide Mononucleotide (NMN) Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey β-Nicotinamide Mononucleotide (NMN) Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturer in 2019
Figure 30. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 35. Global β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Regions (2015-2020)
Figure 37. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Regions in 2018
Figure 38. North America β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
Figure 39. Europe β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
Figure 41. South America β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020)
Figure 43. North America β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries (2015-2020)
Figure 45. North America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries in 2018
Figure 46. North America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries in 2018
Figure 48. United States β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 49. Canada β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 50. Mexico β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 51. Europe β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries (2015-2020)
Figure 53. Europe β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries in 2019
Figure 54. Germany β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 55. UK β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 56. France β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 57. Russia β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 58. Italy β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 59. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Regions 2019
Figure 61. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Regions 2019
Figure 62. China β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 63. Japan β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 64. Korea β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 65. India β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 66. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 67. South America β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries in 2019
Figure 69. South America β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries in 2019
Figure 70. Brazil β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 71. Argentina β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 72. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 77. Egypt β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 78. Turkey β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 79. South Africa β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2015-2020) (Kg)
Figure 80. Global β-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2021-2025) (Kg)
Figure 81. Global β-Nicotinamide Mononucleotide (NMN) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025) (Kg)
Figure 83. Europe Sales β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025) (Kg)
Figure 84. Asia-Pacific Sales β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025) (Kg)
Figure 85. South America Sales β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025) (Kg)
Figure 86. Middle East & Africa Sales β-Nicotinamide Mononucleotide (NMN) Market Forecast (2021-2025) (Kg)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel

---